Cleared Traditional

K073339 - BLOOD COMPONENT RECIPIENT SET WITH STAN...

K073339 is the FDA 510(k) clearance for BLOOD COMPONENT RECIPIENT SET WITH STAN... by Fenwal, Inc.. It is a Class 2 General Hospital device (product code BRZ) cleared through the Traditional 510(k) pathway after a 96-day FDA review.

K073339 · Fenwal, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2008
Decision
96d
Days
Class 2
Risk

K073339 is an FDA 510(k) clearance for the BLOOD COMPONENT RECIPIENT SET WITH STANDARD SIZE FILTER AND INFUSION SET WITH.... Classified as Set, Blood Transfusion (product code BRZ), Class II - Special Controls.

Submitted by Fenwal, Inc. (Lake Zurich, US). The FDA issued a Cleared decision on March 3, 2008 after a review of 96 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Fenwal, Inc. devices

Submission Details

510(k) Number K073339 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 28, 2007
Decision Date March 03, 2008
Days to Decision 96 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
33d faster than avg
Panel avg: 129d · This submission: 96d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code BRZ Set, Blood Transfusion
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - BRZ Set, Blood Transfusion

Devices cleared under the same product code (BRZ) and FDA review panel - the closest regulatory comparables to K073339.
Blood Administration Sets
K220558 · Baxter Healthcare Corporation · Nov 2022
Blood Administration Set
K210335 · Baxter Healthcare Corporation · Jun 2021
MODIFIED BLOOD RECIPIENT SET
K993120 · Baxter Healthcare Corp · Nov 1999
IV ADMINISTRATION SET
K871908 · Travenol Laboratories, S.A. · Jul 1987
CHURCHILL BLOOD ADMINISTRATION SET
K864441 · Churchill Corp. · Jan 1987
VYGON EXCHANGE TRANSFUSION TRAY 275.00
K851477 · Vygon Corp. · May 1985